353.25 -5.05 (-1.41%)

2.6M NSE+BSE Volume

NSE 28 Aug, 2025 3:31 PM (IST)

US FDA Approval
Biocon receives US FDA tentative approval for Sitagliptin Tablets, with a market size of $6.9 bn See details


Biocon Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for BIOCON, BSE:532523 Biocon Ltd.

726 Votes:
Buy 74.93%
Sell 16.39%
Hold 8.68%
BUY
SELL
HOLD
All reports of BIOCON